Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alnylam Pharmaceuticals (NQ: ALNY )

138.88 USD -0.14 (-0.10%)
Official Closing Price Updated: 4:53 PM EDT, Apr 16, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Alnylam Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
94 95 Next >
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
The FDA and CDC announced their recommendation to pause the use of Johnson & Johnson's JNJ COVID-19 vaccine following incidences of severe clots. J&J's pain turned into gains for other COVID-19 vaccine... 
Tags Pharma/Biotech Stocks / Equities Market News
From Blogs - TalkMarkets
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector rebounding along with the broader market. The week's news ... 
Tags BIIB SNDX ISRG
From Benzinga
Alnylam to Webcast Conference Call Discussing First Quarter 2021 Financial Results
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that it will report financial results for the first quarter ending March 31, 2021 on Thursday, April... 
From Business Wire News Releases
Alnylam Presents Positive Late-Breaking Data from Ongoing Phase 1 Study of ALN-AGT, an Investigational RNAi Therapeutic for the Treatment of Hypertension
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today positive interim results from the ongoing Phase 1 study of ALN-AGT, a subcutaneous investigational... 
From Business Wire News Releases
Dicerna Sells Oxlumo Royalty Interest To Royalty Pharma For $180M Upfront
Royalty Pharma plc(NASDAQ:RPRX)has acquiredDicerna Pharmaceuticals Inc's(NASDAQ:DRNA) royalty ... 
Tags Biotech News DRNA
From Benzinga
Alnylam to Webcast Presentation at 20th Annual Needham Virtual Healthcare Conference
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 20th Annual Needham Virtual Healthcare... 
From Business Wire News Releases
Alnylam Pharmaceuticals Larger Than S&P 500 Component NetApp
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Alnylam Pharmaceuticals Inc (ALNY) was identified as having a larger market cap than the smaller end of the... 
Tags Stocks
From Market News Video
Alnylam's Oxalate-Lowering Therapy Shows Significant Clinical Benefit; Data Published In New England Journal Of Medicine
Alnylam Pharmaceuticals Inc(NASDAQ:ALNY) has announced that trial results from the ILLUMINATE-A Phase 3 study evaluating ... 
Tags ALNY Primary Hyperoxaluria Benzinga
From Benzinga
Alnylam Announces Publication of ILLUMINATE-A Phase 3 Study Results for Lumasiran in The New England Journal of Medicine
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that pivotal trial results from the ILLUMINATE-A Phase 3 study of lumasiran, an RNAi therapeutic... 
From Business Wire News Releases
Bullish Two Hundred Day Moving Average Cross - ALNY
In trading on Wednesday, shares of Alnylam Pharmaceuticals Inc (ALNY) crossed above their 200 day moving average of $142.15, changing hands as high as $142.28 per share. Alnylam Pharmaceuticals Inc... 
Tags Stocks
From Market News Video
We Did The Math BBH Can Go To $208
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Alnylam to Webcast Presentation at Stifel 3rd Annual CNS Day
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the Stifel 3rd Annual CNS Day on Thursday, April... 
From Business Wire News Releases
The Week Ahead In Biotech (March 28-April 3): Acadia's Dementia Drug Update, Clinical Readouts, Few Earnings In Holiday-Shortened Week
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The ... 
Tags IMAB SAGE ACAD
From Benzinga
Alnylam to Present Full 9-Month Results from the HELIOS-A Phase 3 Study of Vutrisiran at the American Academy of Neurology Virtual Annual Meeting 2021
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company will present full 9-month results from the HELIOS-A Phase 3 study of vutrisiran, an... 
From Business Wire News Releases
Alnylam, Vir Biotech Deprioritize COVID-19 Drug Development In Hushed Manner
Last week,Vir Biotechnology Inc’s(NASDAQ:VIR) and its collaborating partnerGlaxoSmithKline ... 
Tags News GSK General
From Benzinga
Alnylam Issues Inaugural Corporate Responsibility Summary
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today issued its first Corporate Responsibility (CR) Summary, formalizing the management, tracking and communication... 
From Business Wire News Releases
Soleo Health to Administer Alnylam Pharmaceuticals’ GIVLAARI® (givosiran) for the Treatment of Acute Hepatic Porphyria in Adults
Soleo Health to Administer Alnylam Pharmaceuticals’ GIVLAARI® (givosiran) for the Treatment of Acute Hepatic Porphyria in Adults 
From Business Wire News Releases
After 2 Licensing Deals Will GlaxoSmithKline Acquire Vir?
The relationship could result in a marriage down the line. 
Tags GSK Market News GILD
From Motley Fool
Implied BBH Analyst Target Price: $203
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Alnylam to Webcast Presentations at Upcoming March Investor Conferences
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present company overviews at the following conferences which are being held... 
From Business Wire News Releases
Alnylam to Webcast Presentation at 10th Annual SVB Leerink Global Healthcare Conference
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview at the 10th Annual SVB Leerink Global Healthcare... 
From Business Wire News Releases
Vir Biotechnology and GlaxoSmithKline Expand Their Partnership
The biotech will get $345 million through an upfront payment and equity investment. 
Tags ALNY GILD VIR
From Motley Fool
10 Biggest Price Target Changes For Friday
Morgan Stanley raised Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) price target from $203 to $206. GrubHub shares closed at $164.16 ... 
Tags EAT Benzinga PYPL
From Benzinga
Alnylam Pharmaceuticals Inc (ALNY) Q4 2020 Earnings Call Transcript
ALNY earnings call for the period ending December 31, 2020. 
Tags Market News ALNY
From Motley Fool
Recap: Alnylam Pharmaceuticals Q4 Earnings
Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) remained unaffected after the company reported Q4 results. Quarterly ... 
Tags Earnings ALNY Benzinga
From Benzinga
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2020 and... 
From Business Wire News Releases
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BMY NARI TXG
From Benzinga
Earnings Scheduled For February 11, 2021
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is ... 
Tags KPTI AFRM ALKS
From Benzinga
Preview: Alnylam Pharmaceuticals's Earnings
On Thursday, February 11, Alnylam Pharmaceuticals (NASDAQ:ALNY) will release its latest earnings report. Decipher the announcement with ... 
Tags ALNY Earnings BZI/EP
From Benzinga
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, ... 
Tags Benzinga ALKS CORT
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
94 95 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.